REDDING, Calif. , Aug. 14, 2024 /PRNewswire/ -- According to a new market research report titled, ' Biopharmaceutical Processing Equipment and Consumables Market Size, Share, Forecast, & Trends Analysis by Product Type (Filtration, Chromatography, Bioreactors, Cell Culture Media, Shakers, Services), Application (Vaccine, mAb, R&D) - Forecast to 2031, ' published by Meticulous Research ® , the global biopharmaceutical processing equipment and consumables market was valued at $36.
38 billion in 2023. This market is expected to reach $75.72 billion by 2031 from an estimated $40.
22 billion in 2024, at a CAGR of 9.5% during the forecast period of 2024-2031. Download Sample Report Now- https://www.
meticulousresearch.com/download-sample-report/cp_id=4200 Biopharmaceutical processing involves the study of the discovery, development, and processing of complex medicines using living cells and organisms. Biopharmaceuticals include vaccines, blood and blood components, gene therapies, recombinant therapeutic proteins, and somatic cells.
This market's growth is primarily due to the rising government focus on biologics adoption, key players' focus on increasing manufacturing capacity for biopharmaceuticals, and the growing adoption of disposable bioprocessing equipment & consumables. Further potential for market expansion includes the transition to bioprocessing 4.0, the growing use of customized medications, and emerging economies.
Emerging Economies to Provide Growth Opportunities for th.